{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:23:55Z","timestamp":1768832635754,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006446","name":"Warsaw University Faculty of Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006445","name":"Uniwersytet Warszawski","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["DS 703"],"award-info":[{"award-number":["DS 703"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cbi.2025.111496","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T05:12:25Z","timestamp":1743311545000},"page":"111496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Enhancing cardiac safety: Liposomal ciprofloxacin mitigates anthracycline-induced cardiotoxicity without compromising anticancer efficacy"],"prefix":"10.1016","volume":"414","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-2497","authenticated-orcid":false,"given":"Olga","family":"Swiech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Boguszewska-Czubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111496_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cbi.2025.111496_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cbi.2025.111496_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamacardio.2016.2132","article-title":"Oncocardiology-past, present, and future: a review","volume":"9","author":"Yeh","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2025.111496_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: Part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cbi.2025.111496_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","article-title":"Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia","volume":"20","author":"Tan","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2025.111496_bib6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2025.111496_bib7","article-title":"Novel mechanisms of anthracycline-induced cardiovascular toxicity: a focus on thrombosis","volume":"8","author":"Antoniak","year":"2022","journal-title":"Cardiac Atrophy, and Programmed Cell Death"},{"key":"10.1016\/j.cbi.2025.111496_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2025.111496_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin targets multiple players: a new view of an old problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2025.111496_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1040-8428(97)10007-5","article-title":"Anthracycline-induced cardiotoxicity in children and young adults","volume":"27","author":"Giantris","year":"1998","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cbi.2025.111496_bib11","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","article-title":"Cardiac toxicity 4 to 20 years after completing anthracycline therapy","volume":"266","author":"Steinherz","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2025.111496_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cbi.2025.111496_bib13","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2025.111496_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00686558","article-title":"Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin","volume":"35","author":"Pouna","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111496_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.122.001101","article-title":"Cancer treatment and risk of diastolic dysfunction","volume":"381","author":"Minotti","year":"2022","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2025.111496_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bjc.1981.175","article-title":"Effect of different physiological conditions on the action of adriamycin on Chinese hamster cells in vitro","volume":"44","author":"Born","year":"1981","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2025.111496_bib17","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsomega.9b04479","article-title":"Impact of medium pH on DOX toxicity toward HeLa and A498 cell lines","volume":"5","author":"Trebinska-Stryjewska","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.cbi.2025.111496_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1054\/drup.2000.0119","article-title":"pH and drug resistance in tumors","volume":"3","author":"Raghunand","year":"2000","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.cbi.2025.111496_bib19","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective effects of carvedilol against anthracycline-induced cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2025.111496_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11886-016-0731-z","article-title":"Curing cancer, saving the heart: a challenge that cardioncology should not miss","volume":"18","author":"Cardinale","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.cbi.2025.111496_bib21","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2025.111496_bib22","doi-asserted-by":"crossref","first-page":"487.e1","DOI":"10.1016\/j.ahj.2010.05.037","article-title":"Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment","volume":"160","author":"Cadeddu","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cbi.2025.111496_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ejhf.196","article-title":"Protective effects of spironolactone against anthracycline-induced cardiomyopathy","volume":"17","author":"Akpek","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cbi.2025.111496_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaccao.2019.10.001","article-title":"Effect of eplerenone on diastolic function in women receiving anthracycline-based chemotherapy for breast cancer","volume":"1","author":"Davis","year":"2019","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cbi.2025.111496_bib25","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"Bosch","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2025.111496_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/11536360-000000000-00000","article-title":"Safety profile of the fluoroquinolones: focus on levofloxacin","volume":"33","author":"Liu","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.cbi.2025.111496_bib27","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.bmc.2019.05.038","article-title":"Fluoroquinolones structural and medicinal developments (2013\u20132018): where are we now?","volume":"27","author":"Suaifan","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111496_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104884","article-title":"The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: in silico and in vitro study","volume":"66","author":"Beberok","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2025.111496_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.cbi.2025.111496_bib30","first-page":"891","article-title":"Ciprofloxacin mediated cell growth inhibition, S\/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line","volume":"6","author":"Aranha","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111496_bib31","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0022-5347(05)65283-4","article-title":"Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells","volume":"167","author":"Aranha","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.cbi.2025.111496_bib32","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2263::AID-CNCR7>3.0.CO;2-V","article-title":"The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro","volume":"80","author":"Ebisuno","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2025.111496_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.urology.2003.10.038","article-title":"Antitumor activity of common antibiotics against superficial bladder cancer","volume":"63","author":"Kamat","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.cbi.2025.111496_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0090-4295(99)00064-3","article-title":"Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer","volume":"54","author":"Kamat","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.cbi.2025.111496_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111970","article-title":"Ciprofloxacin and levofloxacin as potential drugs in genitourinary cancer treatment-the effect of dose-response on 2D and 3D cell cultures","volume":"22","author":"Kloskowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111496_bib36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.5506\/APhysPolB.42.859","article-title":"The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines in vitro","volume":"68","author":"Kloskowski","year":"2011","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.cbi.2025.111496_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pharep.2017.07.007","article-title":"Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells","volume":"70","author":"Beberok","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2025.111496_bib38","first-page":"1727","article-title":"Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2 signaling pathway","volume":"52","author":"Beberok","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2025.111496_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells","volume":"86","author":"Herold","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2025.111496_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12885-015-1560-y","article-title":"Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation","volume":"15","author":"Yadav","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2025.111496_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000336130","article-title":"Ciprofloxacin and epirubicin synergistically induce apoptosis in human urothelial cancer cell lines","volume":"88","author":"Engeler","year":"2012","journal-title":"Urol. Int."},{"key":"10.1016\/j.cbi.2025.111496_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12032-022-01787-9","article-title":"The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells","volume":"39","author":"Davary Avareshk","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cbi.2025.111496_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.34.3.398","article-title":"Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans","volume":"34","author":"Mertes","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2025.111496_bib44","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/antibiotics11091193","article-title":"Tissue penetration of antimicrobials in intensive care unit patients: a systematic review\u2014Part II","volume":"11","author":"Viaggi","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.cbi.2025.111496_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10928-016-9486-9","article-title":"A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection","volume":"44","author":"Sadiq","year":"2017","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.cbi.2025.111496_bib46","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1540-8159.2003.00367.x","article-title":"Cardioprotective or cardiotoxic","volume":"26","author":"Katritsis","year":"2003","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.cbi.2025.111496_bib47","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1038\/s41598-020-61624-9","article-title":"Routine, ensemble characterisation of electrophoretic mobility in high and saturated ionic dispersions","volume":"10","author":"Austin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111496_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111496_bib49","series-title":"Test No. 236: Fish Embryo Acute Toxicity (FET) Test, OECD Guidelines for the Testing of Chemicals, Section 2","year":"2013"},{"key":"10.1016\/j.cbi.2025.111496_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0005-2736(02)00659-4","article-title":"Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue","volume":"1609","author":"Davidsen","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2025.111496_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1070\/MC2006v016n02ABEH002234","article-title":"Potentiometric determination of the dissociation constants of epirubicin HCl and irinotecan HCl","volume":"16","author":"Anilanmert","year":"2006","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.cbi.2025.111496_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clay.2015.05.010","article-title":"Influence of pH and antibiotic solubility on the removal of ciprofloxacin from aqueous media using montmorillonite","volume":"114","author":"Jalil","year":"2015","journal-title":"Appl. Clay Sci."},{"key":"10.1016\/j.cbi.2025.111496_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","article-title":"The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro","volume":"47","author":"Watkins","year":"2011","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.cbi.2025.111496_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116023","article-title":"The uses of zebrafish (Danio rerio) as an in vivo model for toxicological studies: a review based on bibliometrics","volume":"272","author":"Zhao","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.cbi.2025.111496_bib55","doi-asserted-by":"crossref","first-page":"dev200133","DOI":"10.1242\/dev.200133","article-title":"Identification of enhancer regulatory elements that direct epicardial gene expression during zebrafish heart regeneration","volume":"149","author":"Cao","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.cbi.2025.111496_bib56","doi-asserted-by":"crossref","DOI":"10.1098\/rsbl.2022.0541","article-title":"Flight for fish in drug discovery: a review of zebrafish-based screening of molecules","volume":"19","author":"Dash","year":"2023","journal-title":"Biol. Lett."},{"key":"10.1016\/j.cbi.2025.111496_bib57","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.3390\/ijms24065656","article-title":"Zebrafish as a model of cardiac pathology and toxicity: spotlight on uremic toxins","volume":"24","author":"Coppola","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111496_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103624","article-title":"Beat-to-beat dynamic regulation of intracellular pH in cardiomyocytes","volume":"25","author":"Lyu","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.cbi.2025.111496_bib59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00395-023-01025-x","article-title":"Statins affect human iPSC-derived cardiomyocytes by interfering with mitochondrial function and intracellular acidification","volume":"119","author":"Somers","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cbi.2025.111496_bib60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fcell.2020.00434","article-title":"Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity","volume":"8","author":"Ma","year":"2020","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T03:41:47Z","timestamp":1745552507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":60,"alternative-id":["S0009279725001267"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111496","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing cardiac safety: Liposomal ciprofloxacin mitigates anthracycline-induced cardiotoxicity without compromising anticancer efficacy","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111496"}}